Building “Off-the-Shelf” Regenerative Cell Therapies: The Next Biotech Revolution | Brian Culley - CEO, Lineage Cell Therapeutics

Episode notes

Send us Fan Mail Today’s conversation sits at the intersection of one of the most ambitious - and most challenging - frontiers in modern medicine: regenerative cell therapy. For decades, the vision has been incredibly compelling - replace damaged or dying cells with healthy ones, and you could potentially restore function in diseases like macular degeneration, spinal cord injury, hearing loss, and even Type 1 diabetes. But while the science has advanced, the field has consistently run into a different kind of barrier: how do you actually manufacture living cells as consistent, scalable, affordable therapies? That’s not just a biology problem - it’s an engineering, manufacturing, and business problem. And it’s one that today’s guest has spent his entire career navigating. Brian Culley brings more than three decades of experience across the life sciences industry, spanning drug development, business development, and executive leadership.

Related episodes across the Index

Other episodes covering the same guests and topics, from across The B2B Podcast Index.

• The Scientist Turned VC Funding the Cure for Aging with Omri Amirav-DroryVentures from The Valley · on Biotech81 / 100
• #244 They Said Surgery Was the Only Option. He Built a Company to Prove Them Wrong | Seth Berge, Regenerative RevivalMost People Don't... But You Do! · on regenerative medicine80 / 100
• The Frontier State of Nonprofit AcceleratorsThe Frontier State Podcast · on Biotech78 / 100
• Leading your cross-disciplinary team, with Dr. Marinna Madrid of Cellino From Founder to Leader · on regenerative medicine74 / 100
• Deep Tech Gold Rush: Smart Boom or Future Bust?Venture Unlocked · on Biotech71 / 100
• S2 Ep28: He Sold 2 Companies… Now He’s Looking for the Next Billion-Dollar FounderENTREPRENEURS WORLDWIDE PODCAST HOSTS RICHARD WARD & ROSAMOND STENHOUSE · on Biotech58 / 100

• Building the Internet of Medicine: How AI Could Transform Children's Healthcare | Dr. Timothy Chou - Founder, Pediatric Moonshot92 / 100
• Inside the Global Biotech Ecosystem - Where Innovation Goes Next | Sara Jane Demy - Founder and CEO, Demy-Colton
• Reversing Cellular Age: The Scientist Who Helped Create iPS Cells Reveals What’s Next - Dr. Koji Tanabe, Ph.D. - Founder and CEO, I Peace Inc.
• The End of High Cholesterol? The First Oral PCSK9 Drug Could Change Heart Medicine Forever - Dr. Norman Lepor, MD - Founder and Director, National Heart Institute
• The Hidden Heart Risk: Amgen’s Dr. Paul Burton on the Future of Preventing Heart Attacks - Dr. Paul Burton, M.D., Ph.D., F.A.C.C., M.R.C.S., F.R.C.P. - Senior Vice President and Chief Medical Officer - Amgen